ClinicalTrialsFinder

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Clinical Trials in Wuhan

1 recruitingWuhan, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.33 enrolled8 locationsNCT06927466